APA (7th ed.) Citation

Musallam, A. A., Aldeeb, R. A., Mansour, R. M., Kassem, M. A. E., Saeed, D. F., Mahdy, M. A., . . . Ibrahim, T. M. (2025). Development of a Novel Drug Delivery System “Nanoemulfoam” for Topical Delivery of Terbinafine Hydrochloride as a Repurposed Therapy in Skin Cancer: Formulation, Optimization, In Vitro Characterization, Ex Vivo Transdermal Permeability, Cytotoxicity Studies, and In Silico Assessment. MDPI AG.

Chicago Style (17th ed.) Citation

Musallam, Abeer A., Reem A. Aldeeb, Riham M. Mansour, Manar Abd El-karim Kassem, Doaa Fayez Saeed, Mahmoud A. Mahdy, Rana M. Abdelnaby, Hanan M. Elnahas, and Tarek M. Ibrahim. Development of a Novel Drug Delivery System “Nanoemulfoam” for Topical Delivery of Terbinafine Hydrochloride as a Repurposed Therapy in Skin Cancer: Formulation, Optimization, In Vitro Characterization, Ex Vivo Transdermal Permeability, Cytotoxicity Studies, and In Silico Assessment. MDPI AG, 2025.

MLA (9th ed.) Citation

Musallam, Abeer A., et al. Development of a Novel Drug Delivery System “Nanoemulfoam” for Topical Delivery of Terbinafine Hydrochloride as a Repurposed Therapy in Skin Cancer: Formulation, Optimization, In Vitro Characterization, Ex Vivo Transdermal Permeability, Cytotoxicity Studies, and In Silico Assessment. MDPI AG, 2025.